stock
AVTX · Avalo Therapeutics, Inc.
What Avalo Therapeutics, Inc. reports to the SEC, read from its filings.
Open in the appPrice
The live AVTX price and today's change.
Sign in to see thisChart
Thirty days of daily bars, with signal levels drawn on them.
Sign in to see thisSignals
The latest signal group Nakagai's scanner recorded on AVTX.
Sign in to see thisOptions positioning
Gamma exposure levels from the options market.
Sign in to see thisTechnicals
Trend, momentum and volatility gauges per timeframe.
Sign in to see thisWhat it is
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Filer (SEC EDGAR)
- EDGAR filing index
- Shares outstanding
- 53,629,989 as of 2026-08-03 (XBRL frame CY2026Q2I)
Key stats
Valuation
- P/E
- Locked
- P/S
- Locked
- P/B
- Locked
- Enterprise value
- Locked
- EV/EBIT
- Locked
- FCF yield
- Locked
Margins
- Gross
- —
- Operating
- —
- Net
- —
Returns
- ROE
- -22.4%
- ROA
- -20.4%
Health
- Current ratio
- 19.3x
- Debt/equity
- —
Deep value
- NCAV
- $365.81M
- NCAV per share
- $6.82
- Price/NCAV
- Locked
- NNWC
- $43.26M
- NNWC per share
- $0.81
- Price/NNWC
- Locked
Valuation and the price multiples are built on the live price. Trailing twelve months to 2026-06-30; balance sheet at 2026-06-30.
Sign in to see thisDebt is long-term debt and its current portion. Commercial paper and short-term borrowings are not counted.
Results
| Period end | Revenue | Gross profit (not reported by this company) | Operating income | Net income | Filing |
|---|---|---|---|---|---|
| 2026-06-30 | — | —Gross profit: unreported by this company. | -$31.52M | -$36.36M | 10-Q filed 2026-08-06 |
| 2026-03-31 | — | —Gross profit: unreported by this company. | -$20.90M | -$19.63M | 10-Q filed 2026-05-13 |
| 2025-12-31 | — | —Gross profit: unreported by this company. | -$19.74M | -$13.72M | DEF 14A filed 2026-04-10 Derived: the full year minus the first three quarters, not a figure this filer reported as a quarter. Assembled from more than one filing; the filing above is only the newest of them. |
| 2025-09-30 | $0 | —Gross profit: unreported by this company. | -$19.20M | -$30.63M | 10-Q filed 2025-11-06 |
| 2025-06-30 | — | —Gross profit: unreported by this company. | -$19.32M | -$20.77M | 10-Q filed 2026-08-06 |
| 2025-03-31 | — | —Gross profit: unreported by this company. | -$14.67M | -$13.15M | 10-Q filed 2026-05-13 |
| 2024-12-31 | $192,000 | —Gross profit: unreported by this company. | -$13.31M | -$35.34M | DEF 14A filed 2026-04-10 Derived: the full year minus the first three quarters, not a figure this filer reported as a quarter. Assembled from more than one filing; the filing above is only the newest of them. |
| 2024-09-30 | $249,000 | —Gross profit: unreported by this company. | -$12.86M | $23.04M | 10-Q filed 2025-11-06 |
- Assets
- $490.78M
- Equity
- $448.66M
Balance as of 2026-06-30.
Ten years
| Fiscal year end | Revenue | Operating income | Net income | Free cash flow |
|---|---|---|---|---|
| 2025-12-31 | $59,000 | -$72.92M | -$78.26M | — |
| 2024-12-31 | $441,000 | -$68.51M | -$35.13M | — |
| 2023-12-31 | $1.92M | -$27.35M | -$31.54M | — |
| 2022-12-31 | $18.05M | -$37.44M | -$41.66M | -$26.85M |
| 2021-12-31 | $5.40M | -$82.13M | -$84.38M | -$71.00M |
| 2020-12-31 | $6.70M | -$72.84M | -$63.50M | -$40.60M |
| 2019-12-31 | $6.75M | -$16.14M | -$16.07M | -$19.40M |
| 2018-12-31 | $7.03M | -$35.38M | -$40.05M | -$3.69M |
| 2017-12-31 | $27.81M | $13.89M | $11.87M | $12.56M |
| 2016-12-31 | $1.15M | -$16.08M | -$16.47M | -$14.61M |
Company filings
since Fri Jul 17 · 3 offering filings in 12 months
events
Results
ResultsAug 68-KExecutive or director change
Executive or director changeJun 238-KOther event
Other eventJun 168-KUnregistered share sale, Shareholder rights changed, Executive or director change, Bylaws or fiscal year change
Unregistered share saleShareholder rights changedExecutive or director changeBylaws or fiscal year changeJun 128-KExecutive or director change, Shareholder vote results
Executive or director changeShareholder vote resultsJun 88-KResults
ResultsMay 138-K
5% owners ()
Nantahala Capital Management, LLC
Stake update
Caligan Partners LP
Stake update
RA Capital Management, L.P.
Stake update
BIOTECHNOLOGY VALUE FUND L P
Stake update
T. Rowe Price Investment Management, Inc.
Stake update
Insiders, politicians and funds
Insider trades, last 90 days
Couldn’t load insider trades
This read is unavailable. Try it again without changing anything on the page.
Politician trades, last 90 days
No politician trades filed in the last 90 days.
News
Stories that named AVTX, and the market events around them.
Sign in to see thisBoard
The AVTX board could not be loaded.
Retry the AVTX boardnakagai
Signals on AVTX come from a rule, not a model.
Nakagai’s scanner records a signal the moment a strategy’s rule matches on the bars. Members read those signals on their own desk, where an agent journals the tape and briefs them in plain English.
Members post on the AVTX board